[1]
N. Borkar, S. Gote, P. Salvi, and K. Khobragade, “Physicians’ perspectives on irritable bowel syndrome, diagnosis and management in India: insights from in-clinic questionnaire-based survey study with a focus on Rifaximin”, Int J Community Med Public Health, vol. 12, no. 11, pp. 5138–5142, Oct. 2025.